A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples